Skip to content

Victor Campenaerts, companion of Vuelta a España leader Jonas Vingegaard, has chosen to end his racing career.

Cyclist Victor Campenaerts of Visma-Lease team is skipping the 16th stage of the Vuelta, scheduled for Poio on Tuesday at noon, due to illness.

Cycling competitor Victor Campenaerts, a teammate of current Vuelta leader Jonas Vingegaard, has...
Cycling competitor Victor Campenaerts, a teammate of current Vuelta leader Jonas Vingegaard, has decided to call it a career.

Victor Campenaerts, companion of Vuelta a España leader Jonas Vingegaard, has chosen to end his racing career.

In a surprising turn of events, Victor Campenaerts, one of the most active riders in the Vuelta a España, will be unable to participate in today's stage (Poio-Castro de Herville) due to illness.

Campenaerts, representing Visma-Lease a Bike, has been a crucial support for team leader Jonas Vingegaard in his bid for the overall win. However, his sudden illness during the decisive third week of the race has left a significant gap in the team's performance.

The ill Campenaerts was seen leaving his hotel in Vigo by taxi on Tuesday morning, wearing a mask, but he will not be starting today's stage. Visma-Lease, Campenaerts' team, reported his illness but has not provided a replacement bike for him.

Jonas Vingegaard, currently in the red jersey, is expected to maintain his position in today's stage. He is still ahead of Joao Almeida in the Vuelta. Campenaerts' absence could potentially shift the dynamics of the competition, adding an unexpected element to the ongoing race.

Campenaerts had been one of the most active riders, alongside Vingegaard, in the Vuelta prior to his illness. His absence could significantly affect his team's performance in today's stage, potentially opening opportunities for other competitors.

The illness of a key rider like Campenaerts serves as a reminder of the unpredictable nature of professional sports. The Vuelta a España continues to unfold with twists and turns, promising an exciting conclusion in the coming days.

Read also: